Effect of nasal mupirocin treatment on extranasal carriage of methicillin-resistant Staphylococcus aureus among pediatric patients admitted to the neonatal intensive care unit

Infect Control Hosp Epidemiol. 2023 Jul;44(7):1174-1176. doi: 10.1017/ice.2022.311. Epub 2023 Jan 11.

Abstract

Decolonization of MRSA detected in the oral cavity and tracheal aspirates occurred in 85% and 58% of neonates, respectively, with nasal mupirocin treatment. Recurrent MRSA colonization occurred in 45% of neonates whose MRSA was detected in the oral cavity at a mean of 19 days. Recurrent MRSA colonization occurred in 58% of neonates whose MRSA was detected in tracheal aspirates at a mean of 23 days.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carrier State / drug therapy
  • Child
  • Humans
  • Infant, Newborn
  • Intensive Care Units, Neonatal
  • Methicillin-Resistant Staphylococcus aureus*
  • Mupirocin / therapeutic use
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus

Substances

  • Mupirocin
  • Anti-Bacterial Agents